Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month Low at $210.31

Mesa Laboratories, Inc. (NASDAQ:MLABGet Rating) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $210.31 and last traded at $210.31, with a volume of 239 shares changing hands. The stock had previously closed at $215.81.

Several analysts recently issued reports on the stock. StockNews.com assumed coverage on shares of Mesa Laboratories in a research report on Thursday, March 31st. They set a “hold” rating for the company. Zacks Investment Research lowered shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, April 6th.

The firm has a market capitalization of $1.14 billion, a P/E ratio of 152.43 and a beta of 0.54. The stock’s 50-day simple moving average is $243.13 and its two-hundred day simple moving average is $278.75. The company has a debt-to-equity ratio of 0.58, a current ratio of 2.59 and a quick ratio of 2.08.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 15th. Shareholders of record on Tuesday, May 31st will be given a $0.16 dividend. The ex-dividend date of this dividend is Friday, May 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.29%. Mesa Laboratories’s payout ratio is currently 44.76%.

In other news, Director John James Sullivan sold 5,192 shares of the business’s stock in a transaction on Tuesday, February 15th. The shares were sold at an average price of $259.42, for a total value of $1,346,908.64. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO John Sakys sold 930 shares of the business’s stock in a transaction on Wednesday, March 23rd. The stock was sold at an average price of $251.29, for a total transaction of $233,699.70. The disclosure for this sale can be found here. Over the last quarter, insiders sold 6,194 shares of company stock valued at $1,598,640. Company insiders own 5.10% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in MLAB. First Trust Advisors LP purchased a new position in shares of Mesa Laboratories in the first quarter worth $567,000. SG Americas Securities LLC purchased a new stake in Mesa Laboratories during the third quarter valued at $584,000. Advisor Group Holdings Inc. raised its stake in Mesa Laboratories by 4.3% during the third quarter. Advisor Group Holdings Inc. now owns 1,118 shares of the medical instruments supplier’s stock valued at $338,000 after purchasing an additional 46 shares in the last quarter. Mackenzie Financial Corp raised its stake in Mesa Laboratories by 10.7% during the third quarter. Mackenzie Financial Corp now owns 1,185 shares of the medical instruments supplier’s stock valued at $358,000 after purchasing an additional 115 shares in the last quarter. Finally, Principal Financial Group Inc. raised its stake in Mesa Laboratories by 118.7% during the third quarter. Principal Financial Group Inc. now owns 73,880 shares of the medical instruments supplier’s stock valued at $22,338,000 after purchasing an additional 40,104 shares in the last quarter. 91.90% of the stock is currently owned by hedge funds and other institutional investors.

Mesa Laboratories Company Profile (NASDAQ:MLAB)

Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries.

Featured Stories

Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.